Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

Why this paper is included

Supporting source evidence:

Additionally, there was a marginally significant difference in omega-3 intake (p = 0.071), vitamin B1 (p = 0.079), and high-fat dairy intake (p = 0.058).Dietary intake among tertiles of MALAT1 and TUG1 transcript level in obese and overweight women (n = 346).VariablesMALAT1 tertilesP-valueP-value*TUG1 tertilesp-valueP-value*CSI tertilesp-valueP-value*T1T2T3T1T2T3T1T2T3 < 0.0350.036 to 0.309 > 0.310 < 0.0530.053 to 0.264 > 0.265N = 115N = 116N = 115N = 117N = 118N = 118T1 (n = 99T2 (n = 104)T3 (n = 76)Mean ± SDMean ± SDEnergy intake (kcal/d)2602.146 ± 854.6112729.974 ± 756.4722587.128 ± 802.0580.355 to 2616.285 ± 847.3182673.289 ± 740.7532606.203 ± 85.7720.798 to 2136.53 ± 601.192650.61 ± 674.273151.67 ± 612.17: Carbohydrate (g/d)372.637 ± 129.305378.590 ± 114.451371.968 ± 127.3650.9100.038366.497 ± 127.078377.799 ± 116.854372.531 ± 122.9250.7890.47166.53 ± 17.2791.41 ± 20.92112.36 ± 28.38 < 0.001Protein (g/d)91.509 ± 32.16593.517 ± 32.10390.450 ± 29.9940.7660.65192.804 ± 33.16093.688 ± 32.40189.847 ± 29.9930.6470.541305.72 ± 102.04385.51 ± 120.18435.97 ± 96.75 < 0.001Fat (g/d)91.461 ± 35.289102.264 ± 35.53190.899 ± 32.6210.0240.01995.301 ± 37.07596.456 ± 33.27792.361 ± 33.6380.6670.59678.52 ± 29.6791.87 ± 26.72116.48 ± 30.520.03Oleic acid27.668 ± 12.02431.339 ± 12.53927.173 ± 10.6780.180.03729.656 ± 13.38028.965 ± 11.32927.349 ± 10.6360.3350.14724.86 ± 11.5026.86 ± 8.7133.18 ± 9.970.06Linoleic acid(g/d)16.378 ± 8.62918.777 ± 9.00816.739 ± 8.3330.0890.22717.840 ± 10.00117.392 ± 8.13216.271 ± 7.0640.3710.28416.85 ± 9.5616.76 ± 7.1018.13 ± 7.14 < 0.001Linolenic acid(g/d)1.112 ± 0.5651.329 ± 0.7011.175 ± 0.6760.0410.0951.195 ± 0.6861.254 ± 0.6541.150 ± 0.5840.4850.5911.03 ± 0.661.19 ± 0.541.50 ± 0.610.46Eicosapentaenoic acid (g/d).032 ± .038.030 ± .039.027 ± .0310.7080.715.027 ± .040.031 ± .034.031 ± .0410.5840.5950.01 ± 0.020.03 ± 0.030.04 ± 0.04 < 0.001Docosahexaenoic acid (g/d).104 ± .115.100 ± .121.090 ± .0970.6360.657.089 ± .120.102 ± .108.104 ± .1250.5980.6060.06 ± 0.060.11 ± 0.120.14 ± 0.13 < 0.001Omega3(g/d)1.243 ± .5611.524 ± .7211.327 ± .6980.0230.1611.254 ± 0.6781.537 ± 0.6941.280 ± 0.6380.0130.071Omega6(g/d)15.815 ± 7.39018.873 ± 8.66516.736 ± 8.0370.0480.24316.726 ± 8.96618.287 ± 8.13416.091 ± 7.0340.1820.470CSI12.686 ± 5.20314.209 ± 6.55612.733 ± 5.1200.0800.21413.348 ± 5.84813.557 ± 5.60313.015 ± 5.6760.7770.877Vitamins Vitamin A (μg/day)827.813 ± 487.105752.772 ± 388.081725.797 ± 335.6690.1690.064766.695 ± 426.826785.934 ± 412.431722.568 ± 361.9420.4880.558 Vitamin D(μg/day)2.113 ± 1.5991.946 ± 1.5951.775 ± 1.3540.2690.2272.031 ± 1.6152.064 ± 1.7431.770 ± 1.3180.3170.350 Vitamin E (mg/day)16.890 ± 9.65417.983 ± 9.29515.943 ± 7.3470.2380.44417.323 ± 9.24117.184 ± 9.25315.969 ± 7.4710.4490.457 Vitamin K(mg/day)326.382 ± 394.962281.308 ± 257.702281.534 ± 252.8850.4670.341358.725 ± 398.292274.180 ± 243.778260.327 ± 255.8170.0380.026 Vitamin B1(mg/day)2.168 ± 0.7852.162 ± 0.6642.138 ± 0.7180.9510.0862.178 ± 0.8142.129 ± 0.6562.178 ± 0.7410.8510.079 Vitamin B2(mg/day)2.326 ± 0.9142.313 ± 0.8862.248 ± 0.8120.7800.3482.345 ± 0.9432.298 ± 0.7882.209 ± 0.8130.4860.211 Vitamin B3(mg/day)26.170 ± 10.67227.192 ± 10.58826.258 ± 9.2730.7140.85427.343 ± 11.56426.162 ± 10.21126.382 ± 9.1250.6660.119 Vitamin B5 (mg/day)6.764 ± 3.0476.449 ± 1.9476.337 ± 2.1420.4110.0406.676 ± 3.0806.597 ± 1.9736.231 ± 2.1090.3550.191 Vitamin B6 (mg/day)2.212 ± 0.7782.247 ± 0.7662.195 ± 0.7540.8800.5342.248 ± 0.8042.225 ± 0.7512.159 ± 0.7360.6690.363 Vitamin B9 (μg/day)712.028 ± 254.965700.400 ± 229.644694.195 ± 221.8410.8550.129705.977 ± 255.521699.482 ± 215.701708.952 ± 0.9540.427 Vitamin B12(μg/day)4.586 ± 2.6724.193 ± 2.1544.153 ± 2.1520.3250.1044.349 ± 2.3324.476 ± 2.8024.122 ± 1.8170.5290.612 Vitamin C (mg/day)184.227 ± 93.514203.590 ± 144.119186.766 ± 116.7270.4330.766177.174 ± 92.955198.530 ± 107.503175.324 ± 106.2730.1750.206Food groups Refined grains (g/d)462.952 ± 210.358504.352 ± 276.564456.405 ± 222.0960.3940.959474.331 ± 232.837486.361 ± 277.966477.577 ± 190.9710.9470.704331.80 ± 219.09379.17 ± 191.55397.52 ± 219.720.01 Whole grains (g/d)65.780 ± 60.59977.167 ± 73.84476.463 ± 74.1800.4060.45679.115 ± 99.96372.368 ± 65.94672.593 ± 65.9380.7710.68753.24 ± 47.7561.59 ± 54.1977.42 ± 73.400.82 Total fiber (g/d)48.369 ± 24.38147.127 ± 19.35548.253 ± 20.4610.8940.19148.277 ± 24.50546.719 ± 18.35848.739 ± 22.5620.7740.321 Vegetables(g/d)401.449 ± 247.507371.634 ± 241.267371.246 ± 246.4370.5830.416362.508 ± 223.788396.610 ± 244.876370.068 ± 248.1300.5370.625288.84 ± 183.46424.89 ± 241.68445.77 ± 262.620.003 Fruits(g/d)422.511 ± 243.382503.688 ± 402.483428.339 ± 291.3930.1130.253385.085 ± 269.311502.820 ± 361.756413.485 ± 267.3870.0110.007388.93 ± 312.69510.63 ± 334.57648.63 ± 34.940.92 Low fat dairy(g/d)314.256 ± 214.851277.691 ± 234.791285.682 ± 202.1950.4300.269283.819 ± 198.639314.929 ± 254.523282.858 ± 193.7190.4600.546 High fat dairy(g/d)85.897 ± 125.843115.513 ± 171.19274.736 ± 114.1510.0860.176109.118 ± 175.067105.271 ± 145.06667.035 ± 102.9160.0610.058 White meat(g/d)40.981 ± 33.03454.027 ± 62.17045.692 ± 30.8100.0920.16445.873 ± 41.94849.213 ± 59.60647.519 ± 32.2170.8640.915 Red meat(g/d)23.683 ± 21.49922.075 ± 18.08620.628 ± 23.7140.5750.46422.138 ± 19.29124.107 ± 25.64319.725 ± 17.6500.3080.369 Organ meat(g/d)2.419 ± 3.4192.452 ± 3.8051.806 ± 2.4400.2720.3371.921 ± 2.6642.292 ± 3.2302.382 ± 4.0510.5580.559 Processed meat(g/d)5.417 ± 11.0606.929 ± 10.7746.760 ± 17.1460.6550.7146.647 ± 14.0834.970 ± 10.1696.804 ± 14.1770.5060.388 Fish (g/d)11.568 ± 11.32711.375 ± 12.8739.447 ± 9.4280.3210.36510.153 ± 11.19510.817 ± 12.42311.507 ± 12.4500.7070.6897.06 ± 6.3312.59 ± 12.2415.62 ± 15.97 < 0.001 Poultry(g/d)29.413 ± 26.02542.651 ± 54.85336.245 ± 27.5600.0420.07335.719 ± 36.86938.396 ± 51.70136.012 ± 28.8690.8640.93123.03 ± 18.7435.25 ± 26.6350.75 ± 62.740.002 Legume(g/d)54.065 ± 50.17542.513 ± 36.35041.552 ± 28.8960.0360.03140.463 ± 32.86851.084 ± 45.34546.099 ± 38.8080.1330.16142.47 ± 34.5751.43 ± 42.4246.40 ± 42.310.27 Nuts(g/d)13.298 ± 15.01217.239 ± 22.34315.789 ± 18.6610.3000.42316.048 ± 19.00217.143 ± 23.30512.541 ± 15.2590.1900.2139.45 ± 10.9914.59 ± 15.6321.40 ± 20.640.25 Olive (g/d)5.529 ± 6.9045.021 ± 6.5184.855 ± 8.5420.7830.7605.171 ± 8.5836.016 ± 7.2353.944 ± 5.8120.1090.121 Egg (g/d)22.059 ± 13.14526.560 ± 19.50025.339 ± 22.3170.1860.23624.769 ± 17.50626.118 ± 21.56123.667 ± 16.1880.6190.68012.60 ± 7.0221.47 ± 9.4033.85 ± 17.9 < 0.001Significant and marginally significant values are in [bold].T, tertile; MALAT1. metastasis associated lung adenocarcinoma transcript 1; TUG1, taurine up-regulated 1; CSI, cholesterol-saturated fat index.P-values resulted from a one-way analysis of variance (ANOVA) test and were reported as mean ± standard deviation (SD).P-values* resulted from the analysis of covariance (ANCOVA) test.

Source: Dietary intake of study population over MALAT1 and TUG1 expression tertiles. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Cross-sectional study.

Cross-sectional study

Examines a population at a particular point in time.

Meta-analysis unclear · Blinding unclear / not reported · Human research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

This cross-sectional study involved 346 women classified as obese and overweight, aged between 18 and 48 years.

Source: Abstract.

In this cross-sectional study, 346 healthy overweight and obese women were selected using community-based multi-stage simple random sampling after considering eligibility criteria.

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

The interaction between MALAT1 and TUG1 with dietary fatty acid quality indices on visceral adiposity index and body adiposity index

Cross-sectional study · Scientific Reports · 2024

Original publication title

The interaction between MALAT1 and TUG1 with dietary fatty acid quality indices on visceral adiposity index and body adiposity index

Niloufar Rasaei; Fatemeh Gholami; Mahsa Samadi; Farideh Shiraseb; Alireza Khadem; Mir Saeed Yekaninejad; Solaleh Emamgholipour; Khadijeh Mirzaei

© The Author(s) 2024

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

At a glance

What does the authors’ abstract report?

We aimed to investigate the interaction between the transcript levels of taurine-upregulated gene 1 (TUG1) and metastasis-associated lung adenocarcinoma transcript 1 (MALAT1) and the Cholesterol-Saturated Fat Index (CSI) in relation to the visceral adiposity index (VAI) and body adiposity index (BAI). This cross-sectional study involved 346 women classified as obese and overweight, aged between 18 and 48 years. Dietary intake and the quality of dietary fat were assessed using a validated and reliable 147-item semi-quantitative food frequency questionnaire, with the Cholesterol-Saturated Fat Index (CSI) used as an indicator.

Transcription levels of MALAT1 and TUG1 were evaluated through real-time polymerase chain reaction following the criteria outlined in the Minimum Information for Publication of Quantitative standards. Serum profiles were measured using standard protocols. We observed a positive association between transcription level of MALAT1 and VAI in both crude (β = 3.646, 95% CI 1.950 to 5.341, p < 0.001) and adjusted (β = 8.338, 95% CI 6.110 to 10.566, p < 0.001) models. Furthermore, after adjusting for confounders, a significant positive interaction was noted between MALAT1 expression and CSI on BAI (β: 0.130, 95% CI 0.019, 0.240, p = 0.022), with a marginal positive interaction observed on VAI (β: 0.718, 95% CI − 0.028, 1.463, p = 0.059).

It seems that there may be a positive interaction between MALAT1 transcription level and CSI on VAI and BAI among overweight and obese women. However, no associations were seen between TUG1 mRNA level and the above-mentioned outcomes. Further functional studies are still required to elucidate this concept.

Authors’ abstract

We aimed to investigate the interaction between the transcript levels of taurine-upregulated gene 1 (TUG1) and metastasis-associated lung adenocarcinoma transcript 1 (MALAT1) and the Cholesterol-Saturated Fat Index (CSI) in relation to the visceral adiposity index (VAI) and body adiposity index (BAI). This cross-sectional study involved 346 women classified as obese and overweight, aged between 18 and 48 years. Dietary intake and the quality of dietary fat were assessed using a validated and reliable 147-item semi-quantitative food frequency questionnaire, with the Cholesterol-Saturated Fat Index (CSI) used as an indicator.

Transcription levels of MALAT1 and TUG1 were evaluated through real-time polymerase chain reaction following the criteria outlined in the Minimum Information for Publication of Quantitative standards. Serum profiles were measured using standard protocols. We observed a positive association between transcription level of MALAT1 and VAI in both crude (β = 3.646, 95% CI 1.950 to 5.341, p < 0.001) and adjusted (β = 8.338, 95% CI 6.110 to 10.566, p < 0.001) models. Furthermore, after adjusting for confounders, a significant positive interaction was noted between MALAT1 expression and CSI on BAI (β: 0.130, 95% CI 0.019, 0.240, p = 0.022), with a marginal positive interaction observed on VAI (β: 0.718, 95% CI − 0.028, 1.463, p = 0.059).

It seems that there may be a positive interaction between MALAT1 transcription level and CSI on VAI and BAI among overweight and obese women. However, no associations were seen between TUG1 mRNA level and the above-mentioned outcomes. Further functional studies are still required to elucidate this concept.

Publication and source details

Original title: The interaction between MALAT1 and TUG1 with dietary fatty acid quality indices on visceral adiposity index and body adiposity index

Niloufar Rasaei; Fatemeh Gholami; Mahsa Samadi; Farideh Shiraseb; Alireza Khadem; Mir Saeed Yekaninejad; Solaleh Emamgholipour; Khadijeh Mirzaei

Scientific Reports · 2024

© The Author(s) 2024https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-11T13:51:19.813585+00:00

DOI: 10.1038/s41598-023-50162-9 · PMC10762150